FontsA A
ContrastA A
Newsletter sign-up [mc4wp_form id="1441"]
  • FAQ
  • Downloads
  • Home
x

bbmri-eric website

  • Find samples and data
  • About
    • Member States & National Nodes
    • Governance
    • Stakeholder Forum
    • Expert Centres
    • Staff
    • Jobs
    • Intranet
    • BBMRI-ERIC Podcast
  • Services & Support
    • Directory
    • Sample/Data Locator
    • BBMRI-ERIC Federated Platform
    • MIABIS
    • MIABIS draft2
    • Access Policies
    • About the Sample/Data Negotiator
    • Colorectal Cancer Cohort
    • Quality Management
    • ELSI Services & Research
    • GDPR Code of Conduct
    • COVID-19 Research
      • List COVID-Ready Samples and Data on our Directory
  • EU Grants
    • B1MG
    • BigPicture
    • BY-COVID
    • canSERV
    • CETOCOEN Excellence TEAMING Phase II
    • CINECA
    • ConcePTION
    • CY-BIOBANK
    • DIAMONDS
    • EDIReX
    • EHDS2 Pilot
    • EJP RD
    • EOSC Future
    • EOSC-Life
    • EPND
    • ERIC Forum
    • EUCAN-Connect
    • EuCanImage
    • euCanSHare
    • HealthyCloud
    • IC2PerMed
    • INTERVENE
    • ISIDORe
    • PROPHET
    • RABBIT 2
    • RI-VIS
    • SPIDIA4P
    • Completed Projects
  • News & Events
    • News
    • Events
  • Contact
  • BBMRI-ERIC Task Forces and Working Groups
Home  - News & Events Overview  -  SPIDIA4P consortium meets in Luxembourg  
  • Find samples and data
  • About
    • Member States & National Nodes
    • Governance
    • Stakeholder Forum
    • Expert Centres
    • Staff
    • Jobs
    • Intranet
    • BBMRI-ERIC Podcast
  • Services & Support
    • Directory
    • Sample/Data Locator
    • BBMRI-ERIC Federated Platform
    • MIABIS
    • MIABIS draft2
    • Access Policies
    • About the Sample/Data Negotiator
    • Colorectal Cancer Cohort
    • Quality Management
    • ELSI Services & Research
    • GDPR Code of Conduct
    • COVID-19 Research
      • List COVID-Ready Samples and Data on our Directory
  • EU Grants
    • B1MG
    • BigPicture
    • BY-COVID
    • canSERV
    • CETOCOEN Excellence TEAMING Phase II
    • CINECA
    • ConcePTION
    • CY-BIOBANK
    • DIAMONDS
    • EDIReX
    • EHDS2 Pilot
    • EJP RD
    • EOSC Future
    • EOSC-Life
    • EPND
    • ERIC Forum
    • EUCAN-Connect
    • EuCanImage
    • euCanSHare
    • HealthyCloud
    • IC2PerMed
    • INTERVENE
    • ISIDORe
    • PROPHET
    • RABBIT 2
    • RI-VIS
    • SPIDIA4P
    • Completed Projects
  • News & Events
    • News
    • Events
  • Contact
  • BBMRI-ERIC Task Forces and Working Groups
  • FAQ
  • Downloads
  • Home

I am looking for information as

Researcher

  • Looking for biobanks
  • Looking for samples & data
  • Looking for trusted partners (Expert Centres)
  • Looking for ELSI guidance
  • Looking for scientific collaboration
  • Looking for advice on standardisation
  • Looking for info on projects
  • Looking for scientific publications

Industry

  • Looking for biobanks
  • Looking for trusted partners (Expert Centres)
  • Looking for samples & data
  • Looking for advice on standardisation
  • Looking for scientific collaboration

Patient

  • Working with patient organisations
  • About ethics, rights & societal issues
  • Looking for general information on BBMRI-ERIC
  • About our scientific collaboration

Citizen

  • FAQs (what is a sample, what is a biobank)
  • Looking for biobanks in your country

Member States

  • Looking for information on your country
  • How to become a Member
  • Looking for reports and statutes
  • Looking for samples & data

SPIDIA4P consortium meets at IBBL in Luxembourg

On April 10th and 11th 2018, IBBL (Integrated Biobank of Luxembourg) hosted the SPIDIA4P consortium meeting at its new premises in Dudelange, Luxembourg.

 

SPIDIA for Personalised Medicine (SPIDIA4P) is a support and coordination action funded by the European Commission under the Horizon 2020 programme. It seeks to initiate, develop and implement a comprehensive portfolio of an additional 13 pan-European pre-analytical CEN/TS and ISO/IS documents, as well as external quality assessment schemes (EQAs), addressing the pre-analytical workflows applied to personalised medicine. Leveraging on its extensive expertise, IBBL is in charge of developing the External Quality Assurance (EQA) schemes that accompany the procedures.

 

IBBL had the pleasure of welcoming over 30 participants from the 19 consortium partners of the SPIDIA4P project. These include representatives from SMEs, public institutions and the German Institute for Standardisation (Deutsches Institut für Normung – DIN). The meeting was chaired by QIAGEN, project coordinator.

 

On the first day, the event provided an overview of the project and its advancement, before delving into the detailed progress report, status and action points specific to the various work packages (WP). In particular, day 1 focused on WP1 (Development of new pan-European and International Standards for pre-analytical workflows needed for Personalized Medicine), WP2 (Develop External Quality Assessment Schemes for the pre-analytical phase), WP4/6 (Project Ethics/data privacy and IP issues and IP management and Ethics requirements) and WP5 (Management). The session terminated with a dinner, where participants had the opportunity to exchange on the proceedings of the day.

 

The first half of the second day was entirely dedicated to discussions on the status of tasks, decisions and action points under WP3 (Implementation and Dissemination of Standards & External Quality Assurance Schemes). The session will ended with the Governing Board meeting.

 

SPIDIA for Personalised Medicine (SPIDIA4P) is a support and coordination action funded by the European Commission under the Horizon 2020 programme. It seeks to initiate, develop and implement a comprehensive portfolio of an additional 134 pan-European pre-analytical CEN/TS and ISO/IS documents, as well as external quality assessment schemes (EQAs), addressing the pre-analytical workflows applied to personalised medicine. Leveraging on its extensive expertise, IBBL is in charge of developing the External Quality Assurance (EQA) schemes that accompany the procedures.

 

“Standardised procedures reduce the incidence of irreproducible pre-clinical and clinical research results and, in this particular case, of diagnostic mistakes”, said Fay Betsou, Chief Scientific Officer at IBBL and leader of WP2. “Ultimately, the goal is to improve disease diagnosis, prognosis and patient stratification”.

 

The SPIDIA4P project receives funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement no. 733112

For more information please visit the official SPIDIA website.

Show me:

  • ALL News & Events
  • Research
  • Press Releases
  • Industry
  • Quality
  • Events
  • Scientific Publications
  • News
  • Vacancies
  • ELSI
  • Projects
  • Webinars
  • Policy

The website was co-funded within ADOPT BBMRI-ERIC, a project that has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 676550.

Neue Stiftingtalstrasse 2/B/6
8010 Graz, Austria

Phone: +43 316 34 99 170
Fax: +43 316 34 99 17-99
Mail: contact@bbmri-eric.eu

 

 

Favourites

  • About us
  • News & Events
  • Publications

Quicklinks

  • Directory
  • Negotiator
  • National Nodes

How to find us

Newsletter sign-up

[mc4wp_form id="1441"]

Follow us

rss feed
(c) BBMRI-ERIC® - Legal Notice - Privacy Notice
TOP
Website by Werbeagentur Rubikon
We use cookies to analyse the traffic on our websites. All personal data is anonymized and not shared with third parties! Click here for more information.
Accept